Filing metadata

Accession number
0000950170-24-075631
Form type
Form 4
Filer
Inozyme Pharma, Inc.
CIK
CIK 1693011
Filed
Jun 20, 2024
Reporting period
Jun 18, 2024
Description
Insider transaction

Explore SEC Filings Hub